Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Common Stockholders

The following table sets forth the computation of basic and diluted net income (loss) per share attributable to common stockholders (in thousands, except share and per share data):

	Three Months Ended March 31,
	2024		2023
Basic EPS
Numerator:
Net income (loss)	$	236,183	$	(4,518)
Less:
Income attributable to options exercises by promissory notes	(726)		—
Income attributable to common stock subject to share repurchase agreements	(724)		—
Income attributable to unvested early exercised options	(1)		—
Net income (loss) attributable to Class A and Class B common stockholders—Basic	$	234,732	$	(4,518)
Denominator:
Weighted-average shares used in computing net income (loss) per share—Basic	335,794,739		373,160,029
Net income (loss) per share attributable to common stock—Basic	$	0.70	$	(0.01)
Diluted EPS
Numerator:
Net income (loss) attributable to AppLovin	236,183		(4,518)
Less:
Income attributable to options exercises by promissory notes	(700)		—
Income attributable to common stock subject to share repurchase agreements	(698)		—
Income attributable to unvested early exercised options	(1)		—
Net income (loss) attributable to Class A and Class B common stockholders—Diluted	$	234,784	$	(4,518)
Denominator:
Weighted-average shares used in computing net income (loss) per share—Basic	335,794,739		373,160,029
Weighted-average dilutive stock awards	12,801,556		—
Weighted-average shares used in computing net income (loss) per share—Diluted	348,596,295		373,160,029
Net income (loss) per share attributable to common stock—Diluted	$	0.67	$	(0.01)

Schedule of Antidilutive Potential Common Shares

The following table presents the forms of antidilutive potential common shares:

	As of March 31,
	2024	2023
Stock options exercised for promissory notes	85,000	1,399,999
Early exercised stock options	559	38,250
Stock options	12,265	10,582,241
Unvested RSUs	2,006,934	16,195,182
ESPP	—	842,419
Total antidilutive potential common shares	2,104,758	29,058,091